FIGURE

FIGURE 3

ID

ZDB-FIG-231228-132

Publication

Valencia-Sama et al., 2023 - SHP2 inhibition with TNO155 increases efficacy and overcomes resistance of ALK inhibitors in neuroblastoma

Other Figures

(all 6)

All Figure Page

Back to All Figure Page

FIGURE 3

TNO155 sensitizes ALK-mutant zebrafish xenografts to ALK inhibitors. Zebrafish embryos (2 dpf) were injected with GFP-expressing Kelly (A), SH-SY5Y (B), or LAN-6 (C) cells costained with DiI dye. At 1 day post injection (1 DPI), xenografted larvae were submersed in TNO155, ceritinib, or lorlatinib alone or in combination treatments and incubated at 35°C for 72 hours. Tumor mass was assessed after 72 hours of drug exposure (4 DPI), and GFP fluorescence (area × pixel intensity) was quantified and normalized to pretreatment (1 DPI). Tumor cell invasion within the yolk-sac was visualized (A and D) and quantified (E) in Kelly larval xenografts treated with TNO155, ceritinib or lorlatinib alone or in combination for 72 hours. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001; ns, not significant.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Cancer Res Commun